Red cell and platelet‐derived microparticles are increased in G6PD‐deficient subjects

No abstract is available for this paper.

• Publication year

  2012

• Venue

  European Journal of Haematology

• Publication date

  2012-11-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1111/ejh.12010PMID 22938511
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The absolute counting of red cell‐derived microparticles with red cell bead by flow rate based assay

  2009cited by this paper
• Quantitation of cell-derived microparticles in plasma using flow rate based calibration.

  2008cited by this paper
• Glucose-6-phosphate dehydrogenase deficiency

  2008cited by this paper
• Activated platelet‐derived microparticles in thalassaemia

  2007cited by this paper
• Cell membrane microparticles in blood and blood products: potentially pathogenic agents and diagnostic markers.

  2006cited by this paper
• Surface exposure of phosphatidylserine in pathological cells

  2005cited by this paper
• ABCA1 gene deletion protects against cerebral malaria: potential pathogenic role of microparticles in neuropathology.

  2005cited by this paper
• Circulating endothelial microparticles in malawian children with severe falciparum malaria complicated with coma.

  2004cited by this paper
• Flow cytometric quantitation of red blood cell vesicles in thalassemia

  2004cited by this paper
• Microparticles in cardiovascular diseases.

  2003cited by this paper
• Sickle blood contains tissue factor-positive microparticles derived from endothelial cells and monocytes.

  2003cited by this paper
• Glucose‐6‐phosphate dehydrogenase (G6PD) mutations in Thailand: G6PD Viangchan (871G>A) is the most common deficiency variant in the Thai population

  2002cited by this paper
• Cellular prion protein is expressed on endothelial cells and is released during apoptosis on membrane microparticles found in human plasma

  2002cited by this paper
• Cell-derived Microparticles Circulate in Healthy Humans and Support Low Grade Thrombin Generation

  2001cited by this paper
• Elevated levels of shed membrane microparticles with procoagulant potential in the peripheral circulating blood of patients with acute coronary syndromes.

  2000cited by this paper
• Importance of glucose-6-phosphate dehydrogenase activity in cell death.

  1999cited by this paper
• Importance of glucose-6-phosphate dehydrogenase activity in cell death.

  1999cited by this paper
• [Glucose-6-phosphate dehydrogenase deficiency and hereditary hemolytic anemia].

  1999cited by this paper
• Characterization of a novel bleeding disorder with isolated prolonged bleeding time and deficiency of platelet microvesicle generation

  1997cited by this paper
• G6PD deficiency.

  1994cited by this paper
• Pharmacokinetics of primaquine in G6PD deficient and G6PD normal patients with vivax malaria.

  1994cited by this paper
• The use of primaquine in malaria infected patients with red cell glucose-6-phosphate dehydrogenase (G6PD) deficiency in Myanmar.

  1994cited by this paper
• Clinical significance of platelet microparticles in autoimmune thrombocytopenias.

  1992cited by this paper
• In vivo recognition and clearance of red blood cells containing phosphatidylserine in their plasma membranes.

  1985cited by this paper
• Insertion of fluorescent phosphatidylserine into the plasma membrane of red blood cells. Recognition by autologous macrophages.

  1983cited by this paper
• International Committee for Standardization in Haematology: Recommended Screening Test for Glucose‐6‐Phosphate Dehydrogenase (G‐6‐PD) Deficiency

  1979cited by this paper
• Glucose-6-phosphate dehydrogenase deficiency.

  1972cited by this paper
• The haemolytic effect of various regimens of primaquine with chloroquine in American Negroes with G6PD deficiency and the lack of an effect of various antimalarial suppressive agents on erythrocyte metabolism.

  1967cited by this paper
• Glucose-6-phosphate dehydrogenase-deficient mice have increased renal oxidative stress and increased albuminuria

  year unknowncited by this paper

• Red Blood Cell Extracellular Vesicles as Key Players in Thromboinflammation

  2025cites this paper
• Red Blood Cell-Derived Extracellular Vesicles: An Overview of Current Research Progress, Challenges, and Opportunities

  2023cites this paper
• Impact of splenectomy on circulating microparticles in patients with sickle cell anemia

  2023cites this paper
• Blood Donors with Thalassemic Trait, Glucose-6-Phosphate Dehydrogenase Deficiency Trait, and Sickle Cell Trait and Their Blood Products: Current Status and Future Perspective.

  2022cites this paper
• Cord Platelet Count of Full-Term Neonates in Relation to ABO Incompatibility and Glucose-6-Phosphate Dehydrogenase Levels: A Retrospective Cohort Study

  2022cites this paper
• Blood Cell-Derived Microvesicles in Hematological Diseases and beyond

  2022cites this paper
• Cell-Derived Microparticles in Blood Products from Blood Donors Deficient in Glucose-6-Phosphate Dehydrogenase.

  2021cites this paper
• Centrifugation Removes a Population of Large Vesicles, or “Macroparticles,” Intermediate in Size to RBCs and Microvesicles

  2021influential citation
• The Controversial Role of Glucose-6-Phosphate Dehydrogenase Deficiency on Cardiovascular Disease: A Narrative Review

  2021influential citation
• Glucose-6-Phosphate Dehydrogenase Deficiency and the Benefits of Early Screening

  2020cites this paper
• Thalassemia trait and G6PD deficiency in Thai blood donors.

  2019cites this paper
• Impact of G6PD status on red cell storage and transfusion outcomes.

  2019cites this paper
• Redox Status, Procoagulant Activity, and Metabolome of Fresh Frozen Plasma in Glucose 6-Phosphate Dehydrogenase Deficiency

  2018cites this paper
• Squeezing for Life – Properties of Red Blood Cell Deformability

  2018cites this paper
• Circulating microparticles and the risk of thromboembolic events in Egyptian beta thalassemia patients

  2017cites this paper
• Glucose-6-Phosphate Dehydrogenase Deficiency Mimicking Atypical Hemolytic Uremic Syndrome.

  2017cites this paper
• Potatoes: Source of Laboratory Reagent for Human Platelets Research

  2016cites this paper
• Red blood cell-derived microparticles: An overview.

  2016cites this paper
• Growing thrombi release increased levels of CD235a+ microparticles and decreased levels of activated platelet‐derived microparticles. Validation in ST‐elevation myocardial infarction patients

  2015cites this paper
• Changes in red blood cell membrane structure in G6PD deficiency: an atomic force microscopy study.

  2015cites this paper
• Glucose‐6‐phosphate dehydrogenase deficiency in Italian blood donors: prevalence and molecular defect characterization

  2014cites this paper
• Circulating membrane-derived microvesicles in redox biology.

  2014cites this paper
• Hypoxia Biomarkers, Oxidative Stress, and Circulating Microparticles in Pediatric Patients With Thalassemia in Upper Egypt

  2014cites this paper
• Thalassemia in Upper Egypt Hypoxia Biomarkers , Oxidative Stress , and Circulating Microparticles in Pediatric Patients With

  2014cites this paper
• Red blood cell vesiculation in hereditary hemolytic anemia

  2013cites this paper
• Acute and Chronic Toxicity of Thioacteamide and Alterations in Blood Cell Indices in Rats

  2013cites this paper
• Red cell‐ and platelet‐derived microparticles in G6PD: any other confounding?

  2013cites this paper
• Survival of red blood cells after transfusion: processes and consequences

  2013cites this paper